Drawing for PROCASTAT

USPTO serial 79003754

PROCASTAT

Reviewed by CopyMark Law Group

Reg. 3029338Status 404
Filing date
Status date
Registration date
Dec 13, 2005
Examiner
RIRIE, VERNA BETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROCASTAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Clinical medical reagents for use in gene therapy; pharmaceutical preparations, namely, vaccines for use in gene therapy; therapeutic compositions containing liposome reagents or nucleic acid suitable for gene therapy for use in the treatment of cancer and auto-immune disorders; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS-related infections and bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularization diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; pharmaceutical preparations and vaccines for use in the treatment of cancer, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularization, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; enzymes and enzymatic preparations for medical use in the treatment of bacterial infections; retroviral vector preparations for medical use in the treatment of cancer; and chemotherapeutics for medical useSECTION 71 - CANCELLED—
010Instruments and apparatus for the administration of gene therapy products, namely, vials, syringes, injectors, catheters and tubes; and surgical and medical apparatus and instruments, namely, scalpels, knives, forceps and surgical clipsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 30, 2014INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 18, 2014DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 18, 2014DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 21, 2014INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 30, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 30, 2013C71TCANCELLED SECTION 71—
Sep 28, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 31, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 31, 2006FIMPFINAL DISPOSITION PROCESSED—
Jul 28, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 13, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 20, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2005NPUBNOTICE OF PUBLICATION—
Jun 1, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 27, 2005ALIEASSIGNED TO LIE—
May 24, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 2005XAECEXAMINER'S AMENDMENT ENTERED—
May 4, 2005GNEAEXAMINERS AMENDMENT E-MAILED—
May 4, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 1, 2005CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 31, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 8, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 14, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 14, 2005MAILPAPER RECEIVED—
Oct 14, 2004RFNTREFUSAL PROCESSED BY IB—
Sep 21, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2004DOCKASSIGNED TO EXAMINER—
Aug 16, 2004NWAPNEW APPLICATION ENTERED—
Aug 12, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance